« Previous
Next »
Titles
- Registration and listing of cosmetic product facilities and products: guidance for industry1
- Regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps): small entity compliance guide : guidance for industry1
- Regulatory requirements for hearing aid devices and personal sound amplification products: guidance for industry and Food and Drug Administration staff1
- Reimbursement mechanisms and challenges in team-based behavioral health care1
- Replacement reagent and instrument family policy for in vitro diagnostic devices: guidance for industry and Food and Drug Administration staff1
- Report on the affordability of insulin1
- Reproductive health care in carceral facilities: identifying what we know and opportunities for further research1
- Requirements for additional traceability records for certain foods: what you need to know about the FDA regulation : guidance for industry : small entity compliance guide1
- Resident and facility factors associated with high risk of discharge from nursing facilities, 2012-2017: final report1
- Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report1
- Restoring the public charge policy1
- Resumption of Medicaid eligibility reassessments: over 1 million enrollees ages 50 to 64 could lose their benefits1
- Review of Medicare administrative contractor information security program evaluations for fiscal year 20221
- Review of personnel shortages in federal health care programs during the COVID-19 pandemic1
- Righting a wrong: advancing equity in child care funding for American Indian & Alaska Native families1
- Room to grow: inequities in children's health insurance coverage1
- Routine vaccinations: adult rates vary by vaccine type and other factors : report to congressional requesters1